The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Clinical

The Cancer Letter wins investigative, design awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Cancer Letter won four 2018 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists:

  • Investigative Journalism, Newsletter/Trade Publications, first place, for “A Coup D’état, and a $12M Deal at the University of Utah,” by Paul Goldberg and Matthew Ong (The Cancer Letter, April 21, April 28, May 5, 2017)

  • Front Page Design, Newsletter/Trade Publications, first place, for “43 Years Later: A Redesign of The Cancer Letter,” By Jacqueline Ong and Katherine Goldberg

  • Photo Illustration, Newsletter/Trade Publications, first place, for “Oncology as Art in 2017,” by Katherine Goldberg

  • Series, Newsletter/Trade Publications, finalist, for “Real-World Data: A New Frontier in Cancer Bioinformatics,” by Matthew Ong (The Cancer Letter, June 2, June 9, 2017)

This is the first time The Cancer Letter has won design awards. Every week, our illustrator, Katherine Goldberg, offers a smart, irreverent take on events in oncology. Jacqueline Ong, our designer, undertook a snazzy redesign of the PDF version of The Cancer Letter.

Here are a few of The Cancer Letter’s award-winning covers:

Table of Contents

YOU MAY BE INTERESTED IN

PodcastThe Directors

The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes

Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019). 
By Sara Willa Ernst and Paul Goldberg
Trials & Tribulations

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.
By Richard M. Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account